ArticleMolecules and cells2022

RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors.

Masamitsu Mikami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.